BioAlert Lp15
BioAlert Lp15 - A Legionella automated monitoring device that ensures complete control over the Legionnaire disease risks arising from cooling towers
This solution aims to provide a practical and cost-efficient solution to secure cooling towers and hot water systems from legionella contamination. Indeed, the lack of on-site rapid screening tools leads to reactive responses and are not suitable to prevent legionella contamination.
BioAlert is an automated and connected device, installed directly on the water system that allows real-time surveillance and just-in-time intervention to prevent outbreaks. BioAlert is the best management tool that helps reduce associated intervention costs, production downtime and secure the continuity of operations. BioAlert Lp15 unique solution approach of daily monitoring of the water system allows optimization of chemical usage and leads to strong cost and environmental impact reduction. BioAlert is also a safety device that confirms the absence of health risk associated with building operation, leading to making our cities safer and greener.
- Video
- /
- Images
Key features
- •BioAlert Lp15 gives identical results to laboratory tests with 99,8% validated results. The device is more accurate and more robust then culture and qPCR technique against false negatives and false positives
- •BioAlert can secure a maximum of 6 systems simultaneously to ensure the safety of all building's at-risk equipment
- •BioAlert Lp15 detection’s sensitivity level is below 5 CFU/ml, 2 to 4 times below legislation requirement in most part of the world
- •90% reduction in use of shock treatment based on non-oxidizing biocide were obtained on site
- •Monthly shock treatments were replaced by just-in time chemical adjustment leading to a strong reduction of over-use
Profitability
- •BioAlert reduces the use of shock treatment by an average of 90%, which can save up to $30,000 per year
- •BioAlert provides a ROI in less than 20 months
- •Monthly CT shut down due to legionella affects 5% of industrial clients in Quebec, leading to an expensive 24 to 72h plants closure - Better legionellosis management can avoid associate cost
SDG’s of application
Maturity Stage
- Medium and large scale commercialization
- Small scale commercialization
- Initial market commercialization
- Prototype testing in the real world
- Prototype testing 1:1 in the lab
Looking For
Related Topics
The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. This information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.
